This phenomenon has been observed for other diseases and traits and might be due to inter-study heterogeneity with regard to LD and characteristics of the study populations (such as age and APOE status), the accuracy of diagnoses, and the use of unscreened controls in the largest AD meta-analyses [119, 121–123]. The gene discussed is APOE; the disease is Alzheimer disease.